Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Lai: Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment.... (0.11 sec) 

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of …

- prsjournal.com
TYY Lai, WM Chan, DTL Liu, FOJ Luk, DSC … - British Medical Journal, 2008 - bjo.bmj.com
Results: The mean follow-up duration was 12.8 months. At 3 months, the mean
logMAR BCVA improved from 0.61 to 0.51 (p = 0.014), and the mean CFT reduced
from 347 μm to 247 μm (p = 0.015). Despite the visual and anatomical ...
Cited by 5 - Related articles - BL Direct - All 5 versions

The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy


SY Lee, JG Kim, SG Joe, H Chung, YH Yoon - Korean Journal of Ophthalmology: KJO, 2008 - pubmedcentral.nih.gov
Intravitreal bevacizumab was given alone in 8 eyes (Group 1) and in combination
with PDT in 4 eyes (Group 2). Mean follow-up duration was 17 weeks in group 1
and 15 weeks in group 2 after bevacizumab treatment. The mean number of ...
Cited by 5 - Related articles - All 9 versions

Time-dependent effects on contrast sensitivity, near and distance acuity: difference in …


F Ziemssen, M Lüke, KU Bartz-Schmidt, F … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer
Abstract Purpose To report the change of contrast sensitivity (CS) after
photodynamic therapy (PDT) vs full macular translo- cation (FMT) for neovascular
age-related macular degener- ation (AMD), and to relate this to other ...
Cited by 3 - Related articles - BL Direct - All 3 versions

The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic …


M Ghajarnia, S Kurup, A Eller - Seminars in Ophthalmology, 2007 - informahealthcare.com
We describe the clinical course of a patient with therapy refractory polypoidal
choroidal vasculopathy (PCV) who was treated with intravitreal bevacizumab
(IVB). Prior treatments included photodynamic therapy and intravitreal ...
Cited by 9 - Related articles - BL Direct - All 4 versions

Intravitreal bevacizumab (Avastin) with or without


TYY Lai, WM Chan, DTL Liu… - bjo.bmj.com
Timothy YY Lai, Wai-Man Chan, David TL Liu, et al. ... P<P Published online
March 20, 2008 in advance of the print journal. ... 1Timothy YY Lai, MD, FRCS
1,2Wai-Man Chan, FRCP, FRCOphth 2David TL Liu, FRCS 1Fiona OJ Luk, MRCS ...
Related articles

Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal …


M Mauget-Faysse, MQ Maftouhi, E De La … - European journal of ophthalmology, 2006 - 万方数据资源系统
PURPOSE: To determine the safety and efficacy of photodynamic therapy with
verteporfin (V-PDT) in the treatment of exudative idiopathic polypoidal
choroidal vasculopathy (IPCV) lesions that were not suitable for laser ...
Cited by 10 - Related articles - BL Direct - All 4 versions

Functional changes following combined intravitreal bevacizumab and photodynamic therapy …


C Zuo, F Wen, J Li, Y Liu, S Long, S Huang, M … - Graefe's Archive for Clinical and Experimental … - Springer
Abstract Purpose To assess the functional changes of retina in patients affected
by polypoidal choroidal vasculopathy (PCV) after combined intravitreal
bevacizumab and photo- dynamic therapy (PDT) by means of contrast ...
Related articles - All 2 versions

Indikationen für photodynamische Therapie mit Verteporfin im Zeitalter der intravitrealen …


M Stur - Spektrum der Augenheilkunde, 2008 - Springer
Zusammenfassung. Nach Einführung der intravitrealen Therapie ist es zu einem
deutlichen Rückgang der Anwen- dung der photodynamischen Therapie (PDT) mit
Verteporfin gekommen, weil die Resultate nach PDT schlechter sind als nach ...
Related articles

Refractory Neovascular Age-related Macular Degeneration Secondary to Polypoidal …


M Cho, IA Barbazetto, KB Freund - American Journal of Ophthalmology, 2009 - Elsevier
Despite success in the majority of patients enrolled in the MARINA and ANCHOR
trials, there was still a minority of patients who continued to lose vision
despite treatment. In addition, some patients who initially experienced ...
Related articles - All 24 versions

Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy


Y Kurashige, A Otani, M Sasahara, Y Yodoi, … - American journal of ophthalmology, 2008 - Elsevier
The average number of PDT treatments was 1.65. After the 12-month follow-up, 12
eyes required retreatment. Although the mean visual acuity (VA) ± SD before PDT
(0.55 ± 0.38 logarithm of the minimum angle of resolution units) improved ...
Cited by 6 - Related articles - All 22 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google